pharmaceutical investing Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan
pharmaceutical investing EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
